Our Leadership Team

Led by a visionary executive team, the Ceribell Rapid Response EEG system is the first critical care EEG and quickly becoming an important vital sign for the brain.

Executive Team

Jane Chao, PhD

Jane Chao, PhD

CEO and Co-founder
Jane Chao, PhD

Jane Chao, the co-founder and CEO of Ceribell, holds a Ph.D. in biophysics from Cornell University. Before she joined Ceribell, Jane had a solid history of leadership and success in business. She launched her career as a management consultant with McKinsey & Company, and later made her move into the medical space joining Novartis as their Senior Strategy Manager. She then enjoyed a successful career at Genentech as their Principal Manager of Portfolio Management Strategy.
In 2015, Jane started Ceribell full-time as the CEO, the position she currently holds. She has built and led the Ceribell team from early concept stages to a fully commercial, FDA-cleared, clinically proven and highly successful
commercial product that is changing the standard of care for critically ill patients.

Raymond Woo, PhD

Raymond Woo, PhD

CTO
Raymond Woo, PhD

Raymond Woo joined Ceribell in 2016 to lead its product research and development efforts. Throughout his career, Ray has worked to successfully bring innovative and disruptive medical device technologies to market. Prior to Ceribell, he was Global Head of Femtosecond Laser R&D at Abbott Medical Optics (now a part of J&J Vision), where he was responsible for R&D efforts across multiple product lines in both the laser cataract surgery and the laser vision correction markets. He helped to develop the Catalys laser cataract surgery system at Optimedica, which was acquired by Abbott Medical Optics. Ray received a Ph.D. and Master’s degree in Electrical Engineering from Stanford University, where his research focused on novel semiconductor devices. He has a Bachelor’s degree in Electrical
Engineering and Computer Science from Duke University.

Scott Blumberg

Scott Blumberg

CFO
Scott Blumberg

Scott Blumberg, Ceribell’s CFO, has over 15 years of healthcare finance experience, largely focused on the medical device space. Prior to joining Ceribell, Scott served as Managing Advisor of Venture Forward Advisory Services, a financial and strategic consulting agency that he founded. At Venture Forward, served as a trusted advisor and outsourced CFO to 20+ venture-backed startups and emerging growth companies, completing over 100 engagements. Previously, Scott served as Director of Business Development for IDEV Technologies, a Houston based venture-backed medical device company, where he led strategic initiatives including implementing an advanced sales analytics program, sourcing and negotiating multiple partnerships, developing marketing strategies,
and leading the M&A process that resulted in a $310 million sale to Abbott.

Diku Mandavia, MD

Diku Mandavia, MD

CMO
Diku Mandavia, MD

Dr. Diku Mandavia is Chief Medical Officer at Ceribell, focused on driving the company’s mission to develop a new standard of care with non-invasive brain monitoring. Dr. Mandavia, a recognized expert in emergency medicine, brings more than 25 years of clinical experience and nearly 15 years of commercial medical device experience.

Previously, Dr. Mandavia served as the global Chief Medical Officer of FUJIFILM Sonosite Inc. since 2009 and FUJIFILM Medical USA since 2015. He joined Sonosite as a medical advisor in 2007 and played a pivotal role in establishing point-of-care ultrasound as the new standard of care in the ED and ICU. At Sonosite, he was instrumental in taking a disruptive technology in miniaturized ultrasound and developing new care pathways at the point of care. Dr. Mandavia led market development efforts focused on the core markets of emergency medicine, critical care and anesthesia that ultimately led to better patient outcomes at a lower cost.

A Clinical Associate Professor of Emergency Medicine at the University of Southern California, Dr. Mandavia is a recognized educator and lecturer. He received his medical degree from Memorial University in Canada, residency at LAC+USC Medical Center and is a graduate of the Stanford Executive Program. He is also a diplomate of the American Board of Emergency Medicine and a Fellow of the Royal College of Physicians and Surgeons of Canada.

Rafael Donnay

Rafael Donnay

VP of Marketing
Rafael Donnay

Rafael Donnay, Ceribell’s VP of Marketing, joined Ceribell in 2018 with over 15 years of US and international experience in the medtech industry. He started his career in engineering and product development at St. Jude
Medical. He then joined Ardian (acquired by Medtronic) and helped commercialize the novel device-based treatment for hypertension in over 80 countries. Rafael then held marketing leadership roles at Stryker Neurovascular and Philips Image Guided Therapies. Rafael holds a B.S. from Columbia University, M.S. from Stanford University, and an
MBA from the Wharton School of the University of Pennsylvania.

Les Burrows

Les Burrows

VP of Sales
Les Burrows

Les Burrows, VP of Sales for Ceribell, has been in medical device sales for more than 20 years, having started with Stryker Leibinger in 2000. He moved to Integra LifeSciences, working 16 years in multiple roles including VP of Sales and Marketing - Orthobiologics and finally VP-Latin America for all of Integra’s businesses. Prior to joining Ceribell, Les spent 2+ years leading the Chronic Pain Therapies business in the NE for Abbott Laboratories. Les attended the University of New Mexico, where he received his BBA-Marketing and later attended Executive Education Programs at The Wharton School and at Columbia Business School.

Dan Rogy

Dan Rogy

VP of Operations
Dan Rogy

Dan Rogy, Ceribell’s VP of Operation, has over 25 years of medical equipment and disposable device Operations and R&D management experience. He led the R&D and Operation Teams at Outset Medical to commercialize a novel Hemodialysis system. Dan was General Manager at Abbott Laboratories, after the acquisition of OptiMedica, where he was responsible for all medical capital equipment and disposable device operations.
Previously he was Director of R&D at Adiana, acquired by Cytyc Corporation, leading the development and manufacturing of a complex disposable with implant and RF Generator. He also held operational management roles at Eli Lilly/Guidant Corporation supplying equipment to manufacturing sites in England, Ireland and the US. Dan has
multiple patents for disposable and implant devices and completed his business degree at Illinois Central College.

Ceribell investors